Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer
AssigneeAgensys, Inc.
InventorsMary Faris, Pia M. Challita-Eid, Aya Jakobovits, Arthur B. Raitano, Wangmao Ge
Life of this patent
Estimating the term…
Abstract
A novel gene 282P1G3 and its encoded protein, and variants thereof, are described wherein 282P1G3 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 282P1G3 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 282P1G3 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 282P1G3 can be used in active or passive immunization.
Claims3
An isolated polynucleotide that encodes a protein comprising the amino acid sequence of SEQ ID NO:3, wherein the polynucleotide comprises nucleotides 272 to 3946 of SEQ ID NO:2.
Dependencies are inferred from the claim text.